Collection

MHRA Horizon Scanning and Innovation case studies

Case studies showing how the MHRA helped several companies to navigate regulatory processes for launching innovative new medicines and medical devices

• From: Medicines and Healthcare products Regulatory Agency
• Published: 31 July 2015
• Last updated: 29 June 2026 — See all updates

See how MHRA worked together with companies to help them understand and fulfil the regulatory requirements of launching innovative medical products.

Find our more about the work of the MHRA Innovation Accelerator.

Documents

• Horizon Scanning Case Study: What is an Actionable Horizon Scanning Signal (AHSS)?
  • 17 January 2023
  • Case study
• Horizon Scanning Case Study: Guiding principles that can inform the development of Good Machine Learning Practice
  • 14 December 2022
  • Case study
• Horizon Scanning Case Study: Developing standards for Adeno-associated virus gene therapies
  • 16 November 2022
  • Case study
• Horizon Scanning Case Study: Point of Care manufacture
  • 15 July 2022
  • Case study
• Early Access continues during the coronavirus (COVID-19) pandemic
  • 6 April 2021
  • Case study
• Innovation: MHRA’s speedy approval of high dose flu vaccine demonstrates flexibilities in national applications
  • 16 March 2020
  • Case study
• Innovation: Clonal neoantigen specific tumour-infiltrating lymphocytes for cancer treatment
  • 29 January 2020
  • Case study
• Innovation: Queen’s University Belfast
  • 12 July 2016
  • Case study
• Innovation: over 500 UK patients gain early access to new skin cancer treatment
  • 17 December 2015
  • Case study
• Innovation: MHRA advises the Cell Therapy Catapult of regulatory requirements
  • 31 July 2015
  • Case study
• Innovation: MHRA helps Fujifilm future proof manufacturing facility - one of the first in Europe
  • 25 June 2015
  • Case study
• Innovation: early dialogue with MHRA shapes development of UK manufacturing site
  • 26 March 2015
  • Case study
• Innovation: MHRA supports innovative vaccine development at the University of Oxford
  • 3 March 2015
  • Case study
• Innovation: MHRA helps Eisai with state-of-the-art facility
  • 29 January 2015
  • Case study
• Innovation: MHRA helps OxSonics early on
  • 30 December 2014
  • Case study
• Innovation: MHRA gives AstraZeneca early advice
  • 5 December 2014
  • Case study

Published 31 July 2015

Last updated 29 June 2026 — Show all updates

1. 29 June 2026

   Added three supporting case studies to collection

2. 15 July 2022

   Added 'Horizon Scanning Case Study: Point of Care manufacture' to the collection.

3. 6 April 2021

   Added 'Early Access continues during the coronavirus pandemic' to the list of innovation case studies.

4. 19 February 2020

   'MHRA’s speedy approval of high dose flu vaccine demonstrates flexibilities in national applications' case study added to collection.

5. 17 December 2015

   New case study out now: Innovation: Over 500 UK patients gain early access to new skin cancer treatment

6. 31 July 2015

   First published.